プロトンポンプ阻害剤(PPI)と腸内細菌について https://t.co/Bw6ByPVBes https://t.co/b34nhUn7RU https://t.co/CaBKVC4sO5
el microbioma intestinal. https://t.co/V1MkZHeG1Z https://t.co/Gi3gnxNyuO
RT @manriqueDVD: Interacciones fármacos - microbiota https://t.co/UGflBPEKAh
RT @manriqueDVD: Interacciones fármacos - microbiota https://t.co/UGflBPEKAh
Interacciones fármacos - microbiota https://t.co/UGflBPEKAh
"Pharmacomicrobiomics: a novel route towards personalized medicine? https://t.co/FCKtf2Mjho."
Medicina personalizada y microbiota: "Pharmacomicrobiomics" https://t.co/RNckHvuDW4
Microbiota and Drug Response https://t.co/cvf8zgEePc
Pharmacomicrobiomics: a novel route towards personalized medicine? https://t.co/PcMC6lJrIY https://t.co/OHQhr9gACO
RT @GMFHx: Inter-individual heterogeneity in drug response is a current challenge. Combining pharmacogenomics & pharmacomicrobiomics will p…
RT @GMFHx: Inter-individual heterogeneity in drug response is a current challenge. Combining pharmacogenomics & pharmacomicrobiomics will p…
RT @GMFHx: Inter-individual heterogeneity in drug response is a current challenge. Combining pharmacogenomics & pharmacomicrobiomics will p…
RT @GMFHx: Inter-individual heterogeneity in drug response is a current challenge. Combining pharmacogenomics & pharmacomicrobiomics will p…
Inter-individual heterogeneity in drug response is a current challenge. Combining pharmacogenomics & pharmacomicrobiomics will provide major advances in personalized medicine, according to a new review coauthored by @researchumcg @SashaZhernakova et al
RT @SashaZhernakova: Our review on pharmacomicrobiomics and personalized medicine is just published. Very proud to be part of the team and…
RT @SashaZhernakova: Our review on pharmacomicrobiomics and personalized medicine is just published. Very proud to be part of the team and…
RT @SashaZhernakova: Our review on pharmacomicrobiomics and personalized medicine is just published. Very proud to be part of the team and…
RT @SashaZhernakova: Our review on pharmacomicrobiomics and personalized medicine is just published. Very proud to be part of the team and…
RT @SashaZhernakova: Our review on pharmacomicrobiomics and personalized medicine is just published. Very proud to be part of the team and…
RT @LifelinesNL: New review highlights the importance of cohort studies for investigating individual variability in drug #metabolism and un…
New review highlights the importance of cohort studies for investigating individual variability in drug #metabolism and underlying genetic, microbial, dietary factors and their interactions. With special attention given to our subcohorts: #Lifelines-DEEP,
RT @SashaZhernakova: Our review on pharmacomicrobiomics and personalized medicine is just published. Very proud to be part of the team and…
RT @SashaZhernakova: Our review on pharmacomicrobiomics and personalized medicine is just published. Very proud to be part of the team and…
RT @SashaZhernakova: Our review on pharmacomicrobiomics and personalized medicine is just published. Very proud to be part of the team and…
RT @SashaZhernakova: Our review on pharmacomicrobiomics and personalized medicine is just published. Very proud to be part of the team and…
Our review on pharmacomicrobiomics and personalized medicine is just published. Very proud to be part of the team and work with @jingyuan_fu @wijmenga_cisca @researchumcg https://t.co/f6ypOD2l60 https://t.co/L18Vm2F6yl
nuevo concepto aprendido hoy, #Farmacomicrobiómica https://t.co/XUk1Qh7ruo
Pharmacomicrobiomics: a novel route towards personalized medicine? https://t.co/Gu2XMrpWql
RT @ashoks773: Interesting article https://t.co/2q2jSjdApO
RT @wijmenga_cisca: Read our latest review ‘Pharmacomicrobiomics: a novel route towards personalized medicine?’ https://t.co/knLkrEpLed
RT @ashoks773: Interesting article https://t.co/2q2jSjdApO
RT @wijmenga_cisca: Read our latest review ‘Pharmacomicrobiomics: a novel route towards personalized medicine?’ https://t.co/knLkrEpLed
Interesting article https://t.co/2q2jSjdApO
RT @wijmenga_cisca: Read our latest review ‘Pharmacomicrobiomics: a novel route towards personalized medicine?’ https://t.co/knLkrEpLed
Nice review from @wijmenga_cisca. Considering #microbiota modulators powerful as drugs, the next step will be the assessment of their cost-effectiveness. #UEGambassador @my_ueg https://t.co/XWnbHDKtgZ
RT @wijmenga_cisca: Read our latest review ‘Pharmacomicrobiomics: a novel route towards personalized medicine?’ https://t.co/knLkrEpLed
RT @wijmenga_cisca: Read our latest review ‘Pharmacomicrobiomics: a novel route towards personalized medicine?’ https://t.co/knLkrEpLed
RT @wijmenga_cisca: Read our latest review ‘Pharmacomicrobiomics: a novel route towards personalized medicine?’ https://t.co/knLkrEpLed
RT @wijmenga_cisca: Read our latest review ‘Pharmacomicrobiomics: a novel route towards personalized medicine?’ https://t.co/knLkrEpLed
RT @wijmenga_cisca: Read our latest review ‘Pharmacomicrobiomics: a novel route towards personalized medicine?’ https://t.co/knLkrEpLed
Read our latest review ‘Pharmacomicrobiomics: a novel route towards personalized medicine?’ https://t.co/knLkrEpLed
Pharmacomicrobiomics: a novel route towards personalized medicine?... - Doestzada M et al. - https://t.co/IwpzaIff26 #microbiome
Pharmacomicrobiomics: a novel route towards personalized medicine? Protein Cell https://t.co/C7WzpelaH8
"Pharmacomicrobiomics: a novel route towards personalized medicine?" | Protein and Cell https://t.co/Y94WjP1nsc